Schedule 13G ownership disclosure

ACTINIUM PHARMACEUTICALS INC

Common Stock · CUSIP: 00507W206

Event date: 2025-06-30

Filing-level shares
1,371,840
Percent of class
4.39%
  • The Vanguard Group

    Shares: 1,371,840 · Class: 4.39%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000841
Form type
SCHEDULE 13G/A
Filer
Actinium Pharmaceuticals, Inc.
CIK
CIK 1388320
Filed
Jul 29, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub